# Hillhurst Biopharmaceuticals, Inc. — Form D

Hillhurst Biopharmaceuticals, Inc. of MONTROSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-26. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-09-26
- Form: D
- Accession: 0001994336-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.8M
- Investors: 10
- Date of first sale: 2023-09-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-493089

## Issuer

- Name: Hillhurst Biopharmaceuticals, Inc.
- CIK: 0001994336
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2029 VERDUGO BOULEVARD, #125, MONTROSE, CA, 91020
- Phone: (818) 445-5890

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jeff Friedman | Director | Montrose, CA |
| Andrew Gomperts | Director | Montrose, CA |
| Edward Gomperts | Director | Montrose, CA |
| Andrew Gomperts | Executive Officer | Montrose, CA |
| Edward Gomperts | Executive Officer | Montrose, CA |

## More

- [CIK 1994336 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1994336&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001994336-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.